S&P 500   2,694.53 (+1.16%)
DOW   22,969.74 (+1.28%)
QQQ   198.19 (+0.87%)
AAPL   262.26 (-0.08%)
FB   169.62 (+2.46%)
MSFT   165.54 (+0.16%)
AMZN   2,020.57 (+1.15%)
BABA   198.71 (+0.89%)
MU   47.05 (+1.47%)
GE   7.11 (-1.66%)
TSLA   548.80 (+6.31%)
AMD   48.07 (+1.16%)
T   30.51 (+3.60%)
ACB   0.80 (+0.00%)
F   4.77 (+5.07%)
NFLX   372.63 (-1.93%)
BAC   22.26 (+4.07%)
GILD   74.88 (-3.67%)
DIS   101.82 (+2.25%)
S&P 500   2,694.53 (+1.16%)
DOW   22,969.74 (+1.28%)
QQQ   198.19 (+0.87%)
AAPL   262.26 (-0.08%)
FB   169.62 (+2.46%)
MSFT   165.54 (+0.16%)
AMZN   2,020.57 (+1.15%)
BABA   198.71 (+0.89%)
MU   47.05 (+1.47%)
GE   7.11 (-1.66%)
TSLA   548.80 (+6.31%)
AMD   48.07 (+1.16%)
T   30.51 (+3.60%)
ACB   0.80 (+0.00%)
F   4.77 (+5.07%)
NFLX   372.63 (-1.93%)
BAC   22.26 (+4.07%)
GILD   74.88 (-3.67%)
DIS   101.82 (+2.25%)
S&P 500   2,694.53 (+1.16%)
DOW   22,969.74 (+1.28%)
QQQ   198.19 (+0.87%)
AAPL   262.26 (-0.08%)
FB   169.62 (+2.46%)
MSFT   165.54 (+0.16%)
AMZN   2,020.57 (+1.15%)
BABA   198.71 (+0.89%)
MU   47.05 (+1.47%)
GE   7.11 (-1.66%)
TSLA   548.80 (+6.31%)
AMD   48.07 (+1.16%)
T   30.51 (+3.60%)
ACB   0.80 (+0.00%)
F   4.77 (+5.07%)
NFLX   372.63 (-1.93%)
BAC   22.26 (+4.07%)
GILD   74.88 (-3.67%)
DIS   101.82 (+2.25%)
S&P 500   2,694.53 (+1.16%)
DOW   22,969.74 (+1.28%)
QQQ   198.19 (+0.87%)
AAPL   262.26 (-0.08%)
FB   169.62 (+2.46%)
MSFT   165.54 (+0.16%)
AMZN   2,020.57 (+1.15%)
BABA   198.71 (+0.89%)
MU   47.05 (+1.47%)
GE   7.11 (-1.66%)
TSLA   548.80 (+6.31%)
AMD   48.07 (+1.16%)
T   30.51 (+3.60%)
ACB   0.80 (+0.00%)
F   4.77 (+5.07%)
NFLX   372.63 (-1.93%)
BAC   22.26 (+4.07%)
GILD   74.88 (-3.67%)
DIS   101.82 (+2.25%)
Log in

NASDAQ:SYNHSyneos Health Stock Price, Forecast & News

$40.89
-0.13 (-0.32 %)
(As of 04/7/2020 03:49 PM ET)
Add
Compare
Today's Range
$40.21
Now: $40.89
$44.56
50-Day Range
$32.64
MA: $53.48
$73.63
52-Week Range
$30.02
Now: $40.89
$74.25
Volume53,069 shs
Average Volume1.08 million shs
Market Capitalization$4.26 billion
P/E Ratio32.98
Dividend YieldN/A
Beta1.55
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More
Syneos Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.27 out of 5 stars


Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SYNH
CUSIPN/A
Phone919-876-9300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.68 billion
Cash Flow$6.20 per share
Book Value$29.19 per share

Profitability

Net Income$131.26 million

Miscellaneous

Employees24,000
Market Cap$4.26 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive SYNH News and Ratings via Email

Sign-up to receive the latest news and ratings for SYNH and its competitors with MarketBeat's FREE daily newsletter.


Syneos Health (NASDAQ:SYNH) Frequently Asked Questions

How has Syneos Health's stock been impacted by COVID-19 (Coronavirus)?

Syneos Health's stock was trading at $57.30 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SYNH stock has decreased by 28.6% and is now trading at $40.89. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Syneos Health?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Syneos Health.

When is Syneos Health's next earnings date?

Syneos Health is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Syneos Health.

How were Syneos Health's earnings last quarter?

Syneos Health Inc (NASDAQ:SYNH) issued its quarterly earnings results on Thursday, February, 20th. The company reported $1.03 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.01 by $0.02. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.19 billion. Syneos Health had a return on equity of 10.12% and a net margin of 2.81%. Syneos Health's quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.95 EPS. View Syneos Health's earnings history.

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health issued an update on its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share (EPS) guidance of $3.58-3.78 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.65. The company issued revenue guidance of $4.88-5.00 billion, compared to the consensus revenue estimate of $4.94 billion.

What price target have analysts set for SYNH?

10 brokerages have issued twelve-month price objectives for Syneos Health's shares. Their forecasts range from $42.00 to $82.00. On average, they anticipate Syneos Health's stock price to reach $62.20 in the next year. This suggests a possible upside of 52.1% from the stock's current price. View analysts' price targets for Syneos Health.

Has Syneos Health been receiving favorable news coverage?

Media headlines about SYNH stock have trended very negative recently, according to InfoTrie. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Syneos Health earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutSyneos Health.

Are investors shorting Syneos Health?

Syneos Health saw a decline in short interest during the month of March. As of March 13th, there was short interest totaling 6,199,900 shares, a decline of 6.3% from the February 27th total of 6,620,000 shares. Based on an average daily trading volume, of 1,569,000 shares, the short-interest ratio is currently 4.0 days. Approximately 10.0% of the company's shares are short sold. View Syneos Health's Current Options Chain.

Who are some of Syneos Health's key competitors?

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include AT&T (T), NVIDIA (NVDA), Alibaba Group (BABA), Solaredge Technologies (SEDG), CVS Health (CVS), Square (SQ), Constellation Brands (STZ), UnitedHealth Group (UNH), Verizon Communications (VZ) and JD.Com (JD).

Who are Syneos Health's key executives?

Syneos Health's management team includes the following people:
  • Mr. Alistair Macdonald, CEO & Director (Age 49)
  • Mr. Jason M. Meggs, Chief Financial Officer (Age 43)
  • Mr. Jonathan Olefson, Gen. Counsel & Corp. Sec. (Age 43)
  • Mr. Michael Adam Bell, Consultant (Age 63)
  • Mr. Robert Parks, Exec. VP & Chief Accounting Officer

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by many different retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.01%). Company insiders that own Syneos Health stock include Alistair Macdonald, H Lee Equity Fund Vi Thomas, Jason M Meggs, Jonathan Olefson and Paul Colvin. View institutional ownership trends for Syneos Health.

Which institutional investors are buying Syneos Health stock?

SYNH stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have bought Syneos Health stock in the last two years include Jason M Meggs, Jonathan Olefson, and Paul Colvin. View insider buying and selling activity for Syneos Health.

How do I buy shares of Syneos Health?

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $40.89.

How big of a company is Syneos Health?

Syneos Health has a market capitalization of $4.26 billion and generates $4.68 billion in revenue each year. The company earns $131.26 million in net income (profit) each year or $2.83 on an earnings per share basis. Syneos Health employs 24,000 workers across the globe. View additional information about Syneos Health.

What is Syneos Health's official website?

The official website for Syneos Health is http://www.syneoshealth.com/.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at 919-876-9300 or via email at [email protected]

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel